Strikingly, the Man-Alb/clodronate complex (Man-clod) induced a marked reduction in tumor-infiltrating TAMs compared to the other glycosylated albumin/clodronate formulations (Figure 8C). The gene discussed is ALB; the disease is neoplasm.